John Welsh, PhD PALL Biotech

After completing a first degree in Industrial Chemistry at UWIST in Cardiff UK in 1987, John moved to the University of Southampton to do a PhD in Bioorganic Chemistry.

Following completion of a Ph.D  in 1992, he completed a Post Doc at F. Hoffmann La-Roche in Basel investigating the use of peptidomimetics as drugs.

John then went to work with Cobra Biologics in 1994, first developing delivery systems for non-viral gene therapy and later for cytotoxic drugs. He then moved into a role as QC as team leader for Protein Therapeutics Cobra. John joined Pall’s Biotech Process R&D team as Principal Scientist in downstream processing and analytical development in 2011 and was then Promoted to Senior Manager in Biotech Process R&D team with responsibility for direct flow filtration in 2013.

John has since taken on new portfolios in Mixers and Bioreactors, and leads a team of 10 scientists and engineers.